Condition
Clear Cell Sarcoma (CCS) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Clear Cell Sarcoma (CCS) clinical trials that are recruiting, at sites in 3 countries (most in China (1), United Kingdom (1), United States (1)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
Vebreltinib for advanced or metastatic clear cell sarcoma
This study will try taking vebreltinib pills twice daily to treat people aged 12 and older with unresectable or metastatic clear cell sarcoma who have at least one measurable tumor.
-
Weekly tebentafusp for adults with HLA-A*02:01-positive unresectable or metastatic clear cell sarcoma
This trial tests weekly tebentafusp in adults with unresectable or metastatic HLA-A*02:01-positive clear cell sarcoma to see if it controls tumor growth.
Related topics
Quick answers
How many Clear Cell Sarcoma (CCS) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (1 trial), United Kingdom (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.